Plain-English translation of NCT06528626 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two tools designed to catch HIV and hepatitis C infections that often go undiagnosed. Researchers want to see whether adding a self-questionnaire and rapid blood tests (done right at your health center) — in addition to the usual screening methods — helps identify more people who have these infections or are at risk for them.
Many people with HIV or hepatitis C don't know they have these infections because they aren't screened. This trial exists to find out whether these new screening tools can help catch more cases early, when treatment is most effective.
Depending on which group you're assigned to, you may be asked to complete a self-questionnaire about your HIV and hepatitis C risk factors, either on paper or using a QR code on your phone at the health center. You will also have rapid blood tests performed to check for HIV and hepatitis C. The study compares how many people are identified and referred for treatment between the standard screening approach and the new screening tools.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Spain
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Collaborators
Consorcio Centro de Investigación Biomédica en Red (CIBER), European Union
Enrollment target
~240,000 participants
Started
July 2023
Primary completion
January 2025
Age range
14 Years – 65 Years
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Maria J. Vivancos-Gallego, MD, PhD
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal